Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis

@inproceedings{Nakatake2014HyphemaIA,
  title={Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis},
  author={Shunji Nakatake and Shigeo Yoshida and Shintaro Nakao and Ryoichi Arita and Miho Yasuda and Takeshi Kita and Hiroshi Enaida and Yuji Ohshima and Tatsuro Ishibashi},
  booktitle={BMC Ophthalmology},
  year={2014}
}
BackgroundSeveral retinal ischemic diseases can cause neovascular glaucoma (NVG). Trabeculectomy with mitomycin C (MMC) is a relatively better treatment modality in the management of eyes with NVG than other glaucoma surgeries. The aim of this study was to investigate the factors that may influence the outcome of trabeculectomy with MMC for NVG.MethodsForty-nine NVG eyes from 43 patients (26 males and 17 females) underwent primary trabeculectomy with MMC. The mean follow-up period was 16.8 ± 8… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

Efficacy of Ahmed Glaucoma Valve Implantation on Neovascular Glaucoma

  • International journal of medical sciences
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 30 REFERENCES

Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients.

  • Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
  • 2006
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL